{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:35:48Z","timestamp":1770222948065,"version":"3.49.0"},"reference-count":45,"publisher":"American Veterinary Medical Association (AVMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>CASE DESCRIPTION<\/jats:bold> A 5-year-old castrated male Maltese was evaluated for intermittent clinical signs of muscle cramping and abnormal movements of the skin of the right pelvic limb at the site where an infiltrative lipoma had twice been resected. After the second surgery, the surgical field was treated with radiation therapy (RT). The clinical signs developed approximately 14 months after completion of RT.<\/jats:p>\n<jats:p><jats:bold>CLINICAL FINDINGS<\/jats:bold> When clinical signs were present, the right biceps femoris and semitendinosus muscles in the area that received RT were firm and had frequently visible contractions, and the skin overlying those muscles had episodic vermiform movements. Electromyography of those muscles revealed abnormal spontaneous activity with characteristics consistent with myokymic discharges and neuromyotonia. Magnetic resonance imaging of the affected leg revealed no evidence of tumor regrowth. The myokymia and neuromyotonia were considered secondary to RT.<\/jats:p>\n<jats:p><jats:bold>TREATMENT AND OUTCOME<\/jats:bold> 4 U of <jats:italic>Clostridium botulinum<\/jats:italic> toxin type A (BoNT-A) neurotoxin complex was injected into the affected muscles at each of 6 sites twice during a 24-hour period (ie, 48 U of BoNT-A were administered). The clinical signs were completely resolved 10 days after BoNT-A treatment and were controlled by repeated BoNT-A treatment every 3 to 4 months for &gt; 1 year.<\/jats:p>\n<jats:p><jats:bold>CLINICAL RELEVANCE<\/jats:bold> To our knowledge, this is the first report of myokymia and neuromyotonia secondary to RT in a dog. For the dog of this report, injection of BoNT-A into the affected muscles was safe, effective, and easy to perform.<\/jats:p>","DOI":"10.2460\/javma.248.5.532","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T17:40:14Z","timestamp":1455730814000},"page":"532-537","source":"Crossref","is-referenced-by-count":10,"title":["Use of botulinum toxin type A for the treatment of radiation therapy\u2013induced myokymia and neuromyotonia in a dog"],"prefix":"10.2460","volume":"248","author":[{"given":"Cleo P.","family":"Rogatko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric N.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"de Lahunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Vet Comp Oncol","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1476-5810.2004.0053a.x","article-title":"Veterinary co-operative oncology group","volume":"2","author":"Vail","year":"2004"},{"key":"ref2","series-title":"Nat Rev Neurol","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrneurol.2011.226","article-title":"Positive muscle phenomena\u2014diagnosis, pathogenesis and associated disorders","volume":"8","author":"Kortman","year":"2012"},{"key":"ref3","series-title":"Muscle Nerve Suppl","first-page":"S1","volume":"10","year":"2001"},{"key":"ref4","series-title":"Muscle Nerve","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/1097-4598(200102)24:2<151::AID-MUS10>3.0.CO;2-7","article-title":"When is myokymia neuromyotonia?","volume":"24","author":"Gutmann","year":"2001"},{"key":"ref5","series-title":"J Am Anim Hosp Assoc","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5326\/JAAHA-MS-5786","article-title":"The use of botulinum toxin for the treatment of generalized myoclonus in a dog","volume":"49","author":"Schubert","year":"2013"},{"key":"ref6","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tvjl.2013.03.002","article-title":"Myokymia and neuromyotonia in veterinary medicine: a comparison with peripheral nerve hyperexcitability syndrome in humans","volume":"197","author":"Vanhaesebrouck","year":"2013"},{"key":"ref7","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00415-004-0331-5","article-title":"Myokymia and neuromyotonia 2004","volume":"251","author":"Gutmann","year":"2004"},{"key":"ref8","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1939-1676.2010.0525.x","article-title":"Clinical and electrophysiological characterization of myokymia and neuromyotonia in Jack Russell Terriers","volume":"24","author":"Vanhaesebrouck","year":"2010"},{"key":"ref9","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.tvjl.2010.07.011","article-title":"Myokymia and neuromyotonia in 37 Jack Russell Terriers","volume":"189","author":"Bhatti","year":"2011"},{"key":"ref10","series-title":"Vet Rec","first-page":"769","article-title":"\u2018Continuous muscle fibre activity\u2019 in six dogs with episodic myokymia, stiffness and collapse","volume":"155","author":"Van Ham","year":"2004"},{"key":"ref11","series-title":"Vet Rec","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/vr.132.23.587","article-title":"Suspected myokymia in a Yorkshire Terrier","volume":"132","author":"Reading","year":"1993"},{"key":"ref12","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2460\/javma.2005.227.1608","article-title":"Myokymia and neuromyotonia in a cat","volume":"227","author":"Galano","year":"2005"},{"key":"ref13","series-title":"Aust Vet J","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1751-0813.2010.00598.x","article-title":"Unilateral facial myokymia in a dog with an intracranial meningioma","volume":"88","author":"Holland","year":"2010"},{"key":"ref14","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1748-5827.2009.00865.x","article-title":"Inspiratory stridor secondary to palatolingual myokymia in a Maltese dog","volume":"51","author":"Vanhaesebrouck","year":"2010"},{"key":"ref15","series-title":"Vet Rec","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/vr.158.12.411","article-title":"Facial myokymia in a puppy","volume":"158","author":"Walmsley","year":"2006"},{"key":"ref16","series-title":"Ophthalmic Surg","first-page":"280","article-title":"Intractable orbicularis myokymia: treatment alternatives","volume":"20","author":"Jordan","year":"1989"},{"key":"ref17","series-title":"World J Surg Oncol","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1477-7819-6-130","article-title":"Post-radiation sciatic neuropathy: a case report and review of the literature","volume":"6","author":"Gikas","year":"2008"},{"key":"ref18","series-title":"Radiother Oncol","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian","year":"2012"},{"key":"ref19","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2106\/00004623-199173010-00020","article-title":"Post-irradiation femoral neuropathy. A case report","volume":"73","author":"Mendes","year":"1991"},{"key":"ref20","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/1097-0142(197707)40:1<152::AID-CNCR2820400125>3.0.CO;2-E","article-title":"Radiation-induced cranial nerve palsy","volume":"40","author":"Berger","year":"1977"},{"key":"ref21","series-title":"Rev Neurol (Paris)","first-page":"173","article-title":"Post-radiation brachial plexopathy. Persistent conduction block. Myokymic discharges and cramps [in French]","volume":"144","author":"Roth","year":"1988"},{"key":"ref22","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1212\/WNL.45.3.421","article-title":"Magnetic resonance imaging in brachial plexopathy of cancer","volume":"45","author":"Thyagarajan","year":"1995"},{"key":"ref23","series-title":"Muscle Nerve","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/mus.880180611","article-title":"Neuromuscular disorders in systemic malignancy and its treatment","volume":"18","author":"St\u00fcbgen","year":"1995"},{"key":"ref24","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1212\/WNL.34.10.1331","article-title":"Brachial plexopathy: recurrent cancer or radiation?","volume":"34","author":"Lederman","year":"1984"},{"key":"ref25","series-title":"J Support Oncol","first-page":"285","article-title":"The difficulties of diagnosing neuromuscular complications","volume":"3","author":"Mammen","year":"2005"},{"key":"ref26","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/1097-0142(197806)41:6<2154::AID-CNCR2820410612>3.0.CO;2-#","article-title":"Carcinomatous versus radiation-induced brachial plexus neuropathy in breast cancer","volume":"41","author":"Bagley","year":"1978"},{"key":"ref27","series-title":"Folia Neuropathol","first-page":"26","article-title":"Radiation-induced brachial plexus neuropathy\u2014aetiopathogenesis, risk factors, differential diagnostics, symptoms and treatment","volume":"45","author":"Gosk","year":"2007"},{"key":"ref28","series-title":"Radiother Oncol","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0167-8140(90)90057-4","article-title":"Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules","volume":"18","author":"Powell","year":"1990"},{"key":"ref29","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0360-3016(85)90366-9","article-title":"A review of \u03b1\/\u03b2 ratios for experimental tumors: implications for clinical studies of altered fractionation","volume":"11","author":"Williams","year":"1985"},{"key":"ref30","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/0360-3016(94)00422-H","article-title":"Late radiation injury to muscle and peripheral nerves","volume":"31","author":"Gillette","year":"1995"},{"key":"ref31","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0360-3016(89)90110-7","article-title":"Peripheral neuropathies following experimental intraoperative radiation therapy (IORT)","volume":"17","author":"LeCouteur","year":"1989"},{"key":"ref32","series-title":"Nature","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993"},{"key":"ref33","series-title":"Microbiol Rev","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/mr.56.1.80-99.1992","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine","volume":"56","author":"Schantz","year":"1992"},{"key":"ref34","series-title":"Indian J Dermatol","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/0019-5154.60343","article-title":"Botulinum toxin","volume":"55","author":"Nigam","year":"2010"},{"key":"ref35","series-title":"Muscle Nerve Suppl","first-page":"S146","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology","volume":"6","author":"Brin","year":"1997"},{"key":"ref36","series-title":"Surv Ophthalmol","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","article-title":"Botulinum toxin in ophthalmology","volume":"52","author":"Dutton","year":"2007"},{"key":"ref37","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004"},{"key":"ref38","series-title":"World J Pediatr","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12519-013-0442-0","article-title":"Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy","volume":"9","author":"Wang","year":"2013"},{"key":"ref39","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/mds.870100527","article-title":"Botulinum toxin A is effective in treating trismus associated with postradiation myokymia and muscle spasm","volume":"10","author":"Lou","year":"1995"},{"key":"ref40","series-title":"J Bone Joint Surg Am","first-page":"2377","article-title":"Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy","volume":"86-A","author":"Kay","year":"2004"},{"key":"ref41","series-title":"Acta Ophthalmol (Copenh)","first-page":"331","article-title":"Long-term treatment of involuntary facial spasms using botulinum toxin","volume":"68","author":"Ruusuvaara","year":"1990"},{"key":"ref42","series-title":"Am J Ophthalmol","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0002-9394(86)90601-X","article-title":"Absence of antibody production in patients treated with botulinum A toxin","volume":"101","author":"Biglan","year":"1986"},{"key":"ref43","series-title":"J Ocul Pharmacol Ther","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/jop.2012.0119","article-title":"Evaluation of the efficacy and safety of botulinum toxin type A to induce temporary ptosis in dogs","volume":"29","author":"Bittencourt","year":"2013"},{"key":"ref44","series-title":"Aust Vet J","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1751-0813.2003.tb12503.x","article-title":"The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog","volume":"81","author":"Meyer-Lindenberg","year":"2003"},{"key":"ref45","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2460\/javma.240.10.1202","article-title":"Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog","volume":"240","author":"Hansen","year":"2012"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/248\/5\/javma.248.5.532.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/248\/5\/javma.248.5.532.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/248\/5\/javma.248.5.532.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:49:09Z","timestamp":1741348149000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/248\/5\/javma.248.5.532.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":45,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.2460\/javma.248.5.532","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}